Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)

The Pharmacogenomics Journal, Published online: 04 March 2024; doi:10.1038/s41397-024-00328-zPharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)

Source: The Pharmacogenomics Journal - March 4, 2024 Category: Drugs & Pharmacology Authors: Jai N. Patel Chen Jiang Kouros Owzar Daniel L. Hertz Janey Wang Flora A. Mulkey William K. Kelly Susan Halabi Yoichi Furukawa Cameron Lassiter Susan G. Dorsey Paula N. Friedman Eric J. Small Michael A. Carducci Michael J. Kelley Yusuke Nakamura Michiaki K Source Type: research